HLX in AML: Novel prognostic and therapeutic target

Ashley Pandolfi; Ulrich Steidl

doi:10.18632/oncotarget.705

HLX in AML: Novel prognostic and therapeutic target

Ashley Pandolfi, Ulrich Steidl

Cell Biology

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1059-1060
Number of pages	2
Journal	Oncotarget
Volume	3
Issue number	10
DOIs	https://doi.org/10.18632/oncotarget.705
State	Published - 2012

ASJC Scopus subject areas

Oncology

Access to Document

10.18632/oncotarget.705

Cite this

@article{e86d0a1677e442fcbe8fcfc215336ff8,

title = "HLX in AML: Novel prognostic and therapeutic target",

author = "Ashley Pandolfi and Ulrich Steidl",

year = "2012",

doi = "10.18632/oncotarget.705",

language = "English (US)",

volume = "3",

pages = "1059--1060",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "10",

}

TY - JOUR

T1 - HLX in AML

T2 - Novel prognostic and therapeutic target

AU - Pandolfi, Ashley

AU - Steidl, Ulrich

PY - 2012

Y1 - 2012

UR - http://www.scopus.com/inward/record.url?scp=84872775420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872775420&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.705

DO - 10.18632/oncotarget.705

M3 - Editorial

C2 - 23888188

AN - SCOPUS:84872775420

SN - 1949-2553

VL - 3

SP - 1059

EP - 1060

JO - Oncotarget

JF - Oncotarget

IS - 10

ER -

HLX in AML: Novel prognostic and therapeutic target

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this